๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Study of Early Scapular Dyskinesis

Recruitingn/aAges 18 Years - anyAllTanta University
NCT07681999 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is a prospective blind study of periscapular muscle thickness measured with MSUS and correlate it with EMG findings.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * The inclusion criterion for the first group is patients with SD with inflammatory characteristics. * The inclusion criterion for the second group is patients complaining of discomfort upon activity. Exclusion Criteria: * The exclusion criteria of the first group included: 1. patients with a history of local trauma 2. patients with surgical intervention, 3. neuromascular de๏ฌcits, 4. chronic chest disease * Exclusion criteria for the second group were: 1. a history of AS or 2. other systemic autoimmune/ rheumatologic disease.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Faculty of medicine, Tanta University
Tanta, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy